查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566092

下肢静脉瘤治疗市场:全球产业分析，规模，占有率，成长，趋势，预测，2024～2031年

Varicose Veins Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 174 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于静脉曲张治疗市场的综合报告。该报告全面评估了主要市场动态，包括市场推动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。本研究报告提供了独家数据和统计数据，概述了 2024 年至 2031 年静脉曲张治疗市场的预期成长轨迹。

主要的洞察

  • 静脉曲张治疗市场规模（2024 年）：8.286 亿美元
  • 预估市场规模（2031 年）：13.221 亿美元
  • 全球市场成长率（2024 年至 2031 年复合年增长率）：6.9%

静脉曲张治疗市场 - 报告范围：

静脉曲张是肿胀、扭曲的静脉，通常是蓝色或深紫色，是由腿部瓣膜和静脉衰弱引起的。治疗方法包括改变生活方式、压力袜、硬化疗法、雷射疗法、静脉热消融术和手术干预。这个市场主要是由于人口老化、久坐的生活方式和肥胖率上升而导致静脉曲张盛行率不断上升。此外，治疗技术的进步和对静脉曲张治疗方案认识的提高预计将推动市场成长。

市场推动因素：

静脉曲张治疗市场是由几个关键因素推动的，包括人口老化的加剧，他们更容易患血管疾病。肥胖和相关健康问题的发生率不断增加，加上久坐的生活方式，进一步推动了对有效静脉曲张治疗的需求不断增长。雷射消融和射频消融等微创治疗的技术进步正在改善患者的治疗效果并提高采用率。此外，人们对静脉曲张治疗相关美容手术的认识和接受度不断提高预计将推动市场成长。

市场阻碍因素：

儘管预计将显示出有希望的成长，但静脉曲张治疗市场面临着与先进治疗选择的高成本相关的课题，这可能限制了一些患者的获得，特别是在新兴市场。此外，缺乏对治疗方案和相关风险的认识可能会阻碍市场成长。有关批准新治疗技术的监管课题也会减缓创新解决方案的推出。

市场机会：

在医疗保健支出增加和注重改善患者治疗结果的推动下，静脉曲张治疗市场呈现出巨大的成长机会。治疗技术的创新，例如非侵入性技术和改进的手术技术，有望提高静脉曲张治疗的有效性和安全性。预防性医疗保健和生活方式改善的日益增长的趋势为市场参与者提供了製定全面治疗和管理计划的机会。此外，医疗保健提供者和技术公司之间加强合作可能会加速先进治疗方法的开发。

本报告涵盖的主要问题

  • 推动静脉曲张治疗市场全球成长的关键因素是什么？
  • 每个地区最需要哪些治疗方法？
  • 由于技术进步，静脉曲张治疗市场的竞争格局发生了什么样的变化？
  • 谁是静脉曲张治疗市场的主要公司？
  • 全球静脉曲张治疗市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 主要趋势
  • 宏观经济要素
    • 全球各部门展望
    • 全球GDP成长展望
    • 全球医疗费用支出展望
  • COVID-19影响分析
  • 预测要素-相关性及影响

第3章 附加价值的洞察

  • 产品采用分析
  • 疾病流行病学
  • 法规情形
  • 价值链分析
  • 大环境分析
  • 波特的五力分析
  • 由于主要加入企业的推销策略

第4章 全球下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

    • 市场规模(100万美元)和与前一年同期比较成长率
    • 绝对金额机会
  • 市场规模(100万美元)分析与预测
    • 过去的市场规模(100万美元)分析，2019～2023年
    • 目前市场规模(100万美元)的分析与预测，2024～2031年
  • 全球下肢静脉瘤治疗市场展望:治疗
    • 简介/主要调查结果
    • 过去的市场规模(100万美元)分析，不同治疗，2019～2023年
    • 目前市场规模(100万美元)分析与预测，不同治疗，2024～2031年
      • 静脉消融
      • 硬化疗法
      • 手术结扎
    • 市场魅力分析:治疗
  • 全球下肢静脉瘤治疗市场展望:终端用户
    • 简介/主要调查结果
    • 过去的市场规模(100万美元)分析，各终端用户，2019～2023年
    • 目前市场规模(100万美元)的分析与预测，各终端用户，2024～2031年
      • 静脉诊所
      • 医院
      • 门诊病人诊疗单位
    • 市场魅力分析:终端用户

第5章 全球下肢静脉瘤治疗市场展望:各地区

  • 2019～2023年的各地区市场规模(100万美元)的过去分析
  • 目前市场规模(100万美元)分析与预测，各地区，2024～2031年
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 南美
    • 中东·非洲
  • 市场魅力分析:地区

第6章 北美的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第7章 欧洲的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第8章 东亚的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第9章 南亚和大洋洲的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第10章 南美的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第11章 中东·非洲的下肢静脉瘤治疗市场展望:实际成果(2019～2023年)与预测(2024～2031年)

第12章 竞争情形

  • 市场占有率分析，2024年
  • 市场结构
    • 各市场的竞争强度图
    • 竞争仪表板
  • 企业简介(详细内容-概要，财务，策略，最近的趋势)
    • Angio Dynamics
    • Medtronic
    • Teleflex Incorporated
    • Sciton, Inc.
    • Dornier Medtech
    • Merit Medical Systems
    • Alma Lasers
    • Biolitec AG
    • Boston Scientific Corporation

第13章 附录

  • 调查手法
  • 调查的前提
  • 缩写和简称
简介目录
Product Code: PMRREP34797

Persistence Market Research has recently released a comprehensive report on the Varicose Veins Treatment Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the Varicose Veins Treatment Market from 2024 to 2031.

Key Insights:

  • Varicose Veins Treatment Market Size (2024E): USD828.6 Million
  • Projected Market Value (2031F): USD1322.1 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.9%

Varicose Veins Treatment Market - Report Scope:

Varicose veins are swollen, twisted veins that often appear blue or dark purple and are caused by weakened valves and veins in the legs. The treatment options include lifestyle changes, compression stockings, sclerotherapy, laser therapy, endovenous thermal ablation, and surgical interventions. The market is primarily driven by the increasing prevalence of varicose veins due to aging populations, sedentary lifestyles, and rising obesity rates. Moreover, advancements in treatment technologies and increased awareness of varicose vein treatment options are expected to propel market growth.

Market Growth Drivers:

The Varicose Veins Treatment Market is propelled by several key factors, including a growing aging population that is more susceptible to vascular disorders. The increasing incidence of obesity and related health issues, coupled with sedentary lifestyles, further contributes to the rising demand for effective varicose veins treatments. Technological advancements in minimally invasive treatment options, such as laser ablation and radiofrequency ablation, are enhancing patient outcomes and driving adoption rates. Additionally, increased awareness and acceptance of cosmetic procedures related to varicose vein treatments are expected to boost market growth.

Market Restraints:

Despite promising growth prospects, the Varicose Veins Treatment Market faces challenges related to the high costs of advanced treatment options, which may limit accessibility for some patients, especially in developing regions. Additionally, the lack of awareness about treatment options and associated risks can hinder market growth. Regulatory challenges regarding the approval of new treatment technologies may also slow down the introduction of innovative solutions.

Market Opportunities:

The Varicose Veins Treatment Market presents significant growth opportunities driven by rising healthcare expenditures and a focus on improving patient outcomes. Innovations in treatment technologies, such as non-invasive procedures and improved surgical techniques, are expected to enhance the efficacy and safety of varicose vein treatments. The growing trend towards preventive healthcare and lifestyle modifications offers opportunities for market players to develop comprehensive treatment and management plans. Furthermore, increasing collaboration between healthcare providers and technology companies can facilitate the development of advanced treatment modalities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Varicose Veins Treatment Market globally?
  • Which treatment modalities are experiencing the highest demand across different regions?
  • How are technological advancements reshaping the competitive landscape of the Varicose Veins Treatment Market?
  • Who are the key players contributing to the Varicose Veins Treatment Market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Varicose Veins Treatment Market?

Competitive Intelligence and Business Strategy:

Leading players in the Varicose Veins Treatment Market, including Medtronic plc, Boston Scientific Corporation, and AngioDynamics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including minimally invasive techniques and improved sclerotherapy agents. Collaborations with healthcare providers, clinical research organizations, and regulatory agencies facilitate market access and promote technology adoption. Additionally, an emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving landscape of varicose veins treatment.

Key Companies Profiled:

  • Angio Dynamics
  • Medtronic
  • Teleflex Incorporated
  • Sciton, Inc.
  • Dornier Medtech
  • Merit Medical Systems
  • Alma Lasers
  • Biolitec AG
  • Boston Scientific Corporation

Varicose Veins Treatment Market Segmentation

By Treatment

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation

By End User

  • Vein Clinics
  • Hospitals
  • Ambulatory Care Unit

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Varicose Veins Treatment Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis
  • 3.7. Promotional Strategies, By Key Players

4. Global Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
  • 4.3. Global Varicose Veins Treatment Market Outlook: Treatment
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Treatment, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
      • 4.3.3.1. Endovenous Ablation
      • 4.3.3.2. Sclerotherapy
      • 4.3.3.3. Surgical Ligation
    • 4.3.4. Market Attractiveness Analysis: Treatment
  • 4.4. Global Varicose Veins Treatment Market Outlook: End User
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
      • 4.4.3.1. Vein Clinics
      • 4.4.3.2. Hospitals
      • 4.4.3.3. Ambulatory Care Unit
    • 4.4.4. Market Attractiveness Analysis: End User

5. Global Varicose Veins Treatment Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Treatment
    • 6.2.3. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 6.4.1. Endovenous Ablation
    • 6.4.2. Sclerotherapy
    • 6.4.3. Surgical Ligation
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 6.5.1. Vein Clinics
    • 6.5.2. Hospitals
    • 6.5.3. Ambulatory Care Unit
  • 6.6. Market Attractiveness Analysis

7. Europe Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Treatment
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkiye
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 7.4.1. Endovenous Ablation
    • 7.4.2. Sclerotherapy
    • 7.4.3. Surgical Ligation
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 7.5.1. Vein Clinics
    • 7.5.2. Hospitals
    • 7.5.3. Ambulatory Care Unit
  • 7.6. Market Attractiveness Analysis

8. East Asia Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Treatment
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 8.4.1. Endovenous Ablation
    • 8.4.2. Sclerotherapy
    • 8.4.3. Surgical Ligation
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 8.5.1. Vein Clinics
    • 8.5.2. Hospitals
    • 8.5.3. Ambulatory Care Unit
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Treatment
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 9.4.1. Endovenous Ablation
    • 9.4.2. Sclerotherapy
    • 9.4.3. Surgical Ligation
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 9.5.1. Vein Clinics
    • 9.5.2. Hospitals
    • 9.5.3. Ambulatory Care Unit
  • 9.6. Market Attractiveness Analysis

10. Latin America Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Treatment
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 10.4.1. Endovenous Ablation
    • 10.4.2. Sclerotherapy
    • 10.4.3. Surgical Ligation
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 10.5.1. Vein Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Ambulatory Care Unit
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Treatment
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 11.4.1. Endovenous Ablation
    • 11.4.2. Sclerotherapy
    • 11.4.3. Surgical Ligation
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 11.5.1. Vein Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Ambulatory Care Unit
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Angio Dynamics
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medtronic
    • 12.3.3. Teleflex Incorporated
    • 12.3.4. Sciton, Inc.
    • 12.3.5. Dornier Medtech
    • 12.3.6. Merit Medical Systems
    • 12.3.7. Alma Lasers
    • 12.3.8. Biolitec AG
    • 12.3.9. Boston Scientific Corporation

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations